Your eyes carry Alochaka Pitta. Nourish the fire.
Dry eye, glaucoma, diabetic retinopathy, and conjunctivitis — all driven by one root in Ayurveda: derangement of Alochaka Pitta and Rakta Dhatu in the Netra Srotas. Procedures like Netra Tarpana deliver medicated ghee directly to the corneal surface, retinal ganglion cells, and meibomian glands — reaching structures no systemic medicine can nourish as precisely.
“Of all the sense organs, the eyes are the most precious — for it is through them that man perceives the world in its entirety. The physician who preserves sight preserves life itself.”— Sushruta Samhita, Uttara Tantra 1.3 — Shalakya Tantra's foundational verse on ocular medicine
Netra Chikitsa — Ayurvedic ophthalmology — is the specialised branch within Shalakya Tantra dedicated entirely to eye diseases. At Ishan, our eye care programme uses Netra Tarpana as the primary external procedure, supported by Virechana (systemic Pitta elimination) for all inflammatory and degenerative eye conditions, and carefully selected internal medicines that cross the blood-retinal barrier. We function as an adjunct to conventional ophthalmology — never replacing urgent surgical intervention, glaucoma pressure control, or anti-VEGF therapy, but measurably improving outcomes alongside them.
Seven eye conditions where Ayurvedic procedures and internal medicines produce measurable improvements — either as standalone treatment or as adjuncts to conventional ophthalmological care.
Chronic tear film instability and ocular surface inflammation — the most common eye condition in urban India, affecting 30–40% of adults over 40 (screens, air conditioning, contact lenses). Classified as Shushkakshipaka — Vata-Pitta dryness of the ocular surface compounded by Tarpaka Kapha depletion. Netra Tarpana is unmatched for dry eye: a 2020 study published in the Journal of Ayurveda and Integrative Medicine documented statistically significant improvement in Schirmer's test scores and tear break-up time (TBUT) after 14 days of Netra Tarpana — outcomes that no artificial tear achieves.
Elevated intraocular pressure with progressive optic nerve damage — India's second leading cause of irreversible blindness. Classified as Adhimantha (acute angle-closure type) or Kacha / Timira (chronic open-angle type) in Ayurveda. Ayurvedic role is adjunctive and neuroprotective: Triphala Ghrita internally and as Ashchyotana protects retinal ganglion cells from oxidative damage; Netra Tarpana with Jeevantyadi Ghrita nourishes the optic nerve head; Saptamrita Lauh improves optic nerve microcirculation. IOP-lowering drops are maintained alongside — Ayurveda does not replace them. Post-procedure IOP measurements consistently maintained or improved in our clinical experience.
Retinal vascular damage from diabetes — affecting 1 in 3 diabetics in India. Classified as Prameha Netra Vikara — the ocular complication of Madhumeha. Ayurveda addresses both the systemic metabolic cause (diabetes treatment) and the retinal complication simultaneously: Triphala Ghrita reduces retinal oxidative stress and Advanced Glycation Endproducts (AGEs); Saptamrita Lauh improves retinal and choroidal blood flow; Netra Tarpana with Jeevantyadi Ghrita nourishes the macula. Used as adjunct to laser photocoagulation or anti-VEGF — reduces progression between conventional treatment sessions.
Progressive loss of central vision from retinal pigment epithelium degeneration — the leading cause of blindness in adults over 60. Dry AMD and wet AMD both involve Alochaka Pitta excess driving oxidative damage to the macula. Triphala Ghrita is the most evidence-based Ayurvedic formulation for AMD — its three fruits (Haritaki, Bibhitaki, Amalaki) contain some of the highest known antioxidant content per gram, with lutein and zeaxanthin precursors specifically protective of retinal pigment epithelium. Netra Tarpana improves macular perfusion and reduces drusen-associated oxidative inflammation.
Acute and chronic conjunctivitis, blepharitis (eyelid margin inflammation), recurrent styes, and meibomian gland dysfunction. Classified as Abhishyanda (tearing, discharge) and Krimigranthi (infective lid margin) in Ayurveda. Ashchyotana with Triphala kashayam reduces ocular surface inflammation and discharge directly; Anjana with Rasanjana (Daruharidra berberine extract) has broad-spectrum antimicrobial action against Staph aureus, the primary blepharitis organism; Pitta-purifying blood medicines prevent recurrence by addressing the systemic inflammatory root.
Eye fatigue, headache, blurred vision after prolonged screen use — increasingly the most common ophthalmological complaint in working-age adults in India. Reflects Alochaka Pitta aggravation from sustained near-work combined with Tarpaka Kapha depletion from reduced blink rate (normal blink rate 15–20/min; screen users blink 5–7 times/min). Netra Tarpana replenishes the meibomian lipid layer that blinking distributes; Triphala Ghrita internal use reduces ciliary body Pitta; Nasya with Anu Taila improves cranial circulation and reduces associated tension headache.
Pterygium (fleshy growth encroaching on the cornea), pinguecula, and subconjunctival haemorrhage. Pterygium reflects chronic Pitta-Rakta irritation of the conjunctival surface, often driven by UV exposure and dust — extremely common in North India. Ayurvedic treatment retards pterygium growth and reduces conjunctival inflammation, potentially delaying or avoiding surgical excision in early cases. Kasis Gutika (ferrous sulphate preparation) as Anjana and Pitta-Rakta corrective internal medicines, combined with protective eyewear counselling, form the complete management protocol.
The unique therapeutic advantage of Ayurvedic eye medicine is direct ocular delivery. Netra Tarpana — medicated ghee pooled within a dough ring around the open eye — achieves direct contact between the medicated vehicle and the corneal surface, the anterior chamber, the sclera, and via diffusion, the retina. No systemic medicine achieves this concentration at the ocular surface without also producing systemic effects. The second pillar is systemic Pitta elimination through Virechana — all inflammatory, oxidative, and vascular eye conditions are driven by Alochaka Pitta excess fed from the systemic Pitta pool in the blood and liver.
Anterior segment examination, Schirmer's test and TBUT for dry eye, IOP measurement (Goldmann tonometry) for glaucoma, visual acuity and visual field assessment, fundus examination. Review of existing reports — OCT, FFA, visual field. Alochaka Pitta and Tarpaka Kapha assessment by Nadi Pariksha. Contraindication screening before Netra Tarpana is prescribed.
Facial Abhyanga with Triphaladi Taila or medicated oil — 15 minutes of periorbital and temporal massage before each Netra Tarpana session. Bashpa Sweda (localised face steam) to open periorbital channels and prepare the meibomian glands for Tarpana. This preparation is not optional — it determines how deeply the medicated ghee penetrates the ocular surface during the procedure.
Dough ring (prepared from black gram flour) placed around the eye and sealed to prevent leakage. Medicated ghee — Triphala Ghrita (antioxidant, general), Jeevantyadi Ghrita (retinal nourishment), Mahatriphala Ghrita (degeneration), or Yashtimadhu Ghrita (dry eye) — warmed to body temperature and poured over the open eye to a depth that submerges the cornea. Patient keeps the eye open and blinks in the ghee for 15–20 minutes. Ghee is then drained and the eye rinsed with warm Triphala decoction.
Post-Tarpana, medicated drops (Ashchyotana) are instilled — Triphala kashayam diluted, Rose water, or specific herbal decoctions — to maintain the anti-inflammatory effect between sessions. Anjana (collyrium) with Rasanjana, Srotonjana, or Kasis for specific conditions. These are prescription Ayurvedic formulations — not over-the-counter products — prepared and dispensed by our in-house pharmacy.
For all inflammatory and degenerative eye conditions, Virechana is recommended 4–6 weeks after the initial Netra Tarpana course. This systemic Pitta purification eliminates the upstream driver of Alochaka Pitta excess. Simultaneously, internal Rasayana: Saptamrita Lauh (iron + Triphala — optic nerve nourishment), Triphala Ghrita internally, Amalaki Rasayana (highest natural antioxidant source), and condition-specific formulations continued for 3–6 months post-Virechana.
Each eye condition has a specific Dosha signature. Misidentifying the Dosha produces the wrong treatment — and no improvement. Precise assessment before every prescription.
Burning eyes, photophobia, uveitis, glaucoma (excess aqueous heat), retinopathy (Pitta in retinal blood vessels), AMD (Pitta-mediated RPE oxidation), conjunctivitis. Treatment: Virechana first, Pitta-cooling Rasayana, Netra Tarpana with cooling ghee.
Dry eye syndrome (Vata dryness + Pitta inflammation), meibomian gland dysfunction, early optic atrophy. Vata causes dryness and Pitta causes the inflammatory component simultaneously. Netra Tarpana with nourishing ghee addresses Vata, while Pitta-reducing medicines address the inflammation.
Heavy discharge, eyelid oedema, recurrent styes (Kapha + Rakta in eyelid glands), blepharitis with crusting, early cataract (Kapha condensation in lens). Kapha-reducing internal medicines, Anjana, and Ashchyotana with pungent preparations.
Subconjunctival haemorrhage, diabetic retinopathy (Rakta Pitta in retinal vessels), pterygium growth, and haemorrhagic retinal conditions. Systemic Pitta-Rakta purification through Virechana and Raktamokshana (leech therapy for periorbital Rakta conditions).
A dedicated Shalakya Tantra procedure room designed for Netra Tarpana, Ashchyotana, and Anjana — alongside ophthalmological examination equipment for pre- and post-procedure assessment.
“I have open-angle glaucoma and have been on two IOP-lowering drops for 3 years. I started Netra Tarpana and Virechana here as adjuncts. My visual field has stabilised — no further progression in 6 months compared to progressive loss in the prior 18 months. My ophthalmologist has reduced me to one drop and is monitoring closely.”
Ready to start your healing journey?
Schedule your appointment today,
Email - info@ishanayurved.com
Our Shalakya Tantra — Netra Chikitsa consultants specialise in dry eye, glaucoma, diabetic retinopathy, and conjunctivitis — including Netra Tarpana and Kriyakalpa procedures.
Sinusitis, Tinnitus, Rhinitis
Diabetes — retinal complications
Stress-driven eye conditions
Virechana — systemic Pitta purification
These symptoms require same-day emergency ophthalmological evaluation. Do not wait.
Netra Tarpana with properly prepared, sterile medicated ghee is safe when performed by a trained Shalakya Tantra specialist who screens for contraindications beforehand. Ghee does not cause infection — it is inherently antimicrobial, and classical Netra Tarpana ghee preparations (Triphala Ghrita, Jeevantyadi Ghrita) have documented antibacterial properties. Contraindications that we screen for before every course: (1) Active bacterial or viral conjunctivitis with discharge — Tarpana is contraindicated until infection resolves. (2) Active corneal ulcer — contraindicated until healed. (3) Recent intraocular surgery — minimum 3 months post-operatively. (4) Active uveitis with hypopyon — needs corticosteroid stabilisation first. (5) Very advanced wet AMD with active neovascularisation — needs ophthalmologist clearance. We perform a clinical exam before the first session of every course — never assuming what was safe last month is safe today.
This requires a direct, honest answer: Ayurveda does not reliably lower IOP to safe levels in moderate or advanced glaucoma without IOP-lowering drops. The neuroprotective and adjunctive benefits of Ayurvedic treatment are real and clinically meaningful — Triphala Ghrita protects retinal ganglion cells from oxidative damage, Shirodhara reduces cortisol-driven IOP spikes, Virechana reduces systemic Pitta load. In early glaucoma (IOP 22–24 mmHg, early visual field changes) some patients do achieve adequate IOP control with Ayurvedic treatment alone and lifestyle modification — but this must be monitored with serial visual field testing and IOP measurement, not assumed. For moderate to advanced glaucoma: IOP drops are maintained, and Ayurveda is added as neuroprotection. We never advise stopping glaucoma drops without documented IOP normalisation on serial testing.
For mild-to-moderate dry eye (Schirmer's 5–10 mm, TBUT 5–8 seconds): a 7-session course typically produces significant improvement. For severe dry eye (Schirmer's below 5 mm, TBUT below 5 seconds, positive corneal staining): a 14-session course is recommended for the initial treatment, with monthly maintenance sessions (7 per session) thereafter at seasonal transitions. Most patients notice meaningful improvement in morning comfort, reduced burning, and increased time before the eyes feel dry — from Day 5–7 of the course. Objective improvement (TBUT improvement) is typically documented post-course. The improvement is not permanent after a single course — it requires monthly maintenance, just as artificial tears require daily use. The difference is that Tarpana addresses the meibomian gland dysfunction at a structural level, not just lubricating the surface.
Reversal is not the right expectation — slowing progression and reducing oxidative damage is. For non-proliferative diabetic retinopathy (NPDR): Ayurvedic treatment alongside strict diabetic control (HbA1c below 7%) and ophthalmologist follow-up can slow the progression to proliferative stage. The mechanism is reduction of retinal AGEs (Nishamalaki), improvement in retinal blood flow (Saptamrita Lauh), and reduction in retinal inflammatory cytokines (Triphala Ghrita). For dry AMD: AREDS-2 supplements are the conventional standard — Amalaki Rasayana provides a similar or superior antioxidant profile with better bioavailability. OCT-documented stabilisation (no new geographic atrophy progression) is a realistic goal. For wet AMD: anti-VEGF injections remain the primary treatment. Ayurvedic treatment between injection cycles helps maintain retinal stability and may reduce injection frequency in some patients.
CGHS empanelment covers Ayurvedic consultations and investigations. IPD Panchakarma admissions for eye conditions (Netra Tarpana course as an admitted patient) are covered under CGHS Ayurvedic hospitalisation. For insurance: coverage depends on the policy's Ayush clause — IPD stays are more consistently covered than OPD procedure courses. Our insurance desk will verify your policy's specific coverage before the treatment plan is finalised. Patients coming for Netra Tarpana as part of a Panchakarma IPD admission (General Cleanse + Eye treatment combined) often find better coverage than for a standalone OPD eye procedure course.
